We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online trolling, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
How climate change is affecting our brains
Climate change, and its effects on weather patterns and adverse weather events, is likely to negatively affect the health of people with brain conditions, says a team of researchers led by Epilepsy Society's Director of Genomics, Professor Sanjay Sisodiya.
New video for sharing - 'Epilepsy - it's more than just seizures'
This year National Epilepsy Week runs from 20-26 May 2024 and we will be launching our brand new epilepsy awareness video “Epilepsy – it’s more than just seizures.”
National Epilepsy Week 2024
20 May marks the start of National Epilepsy Week 2024. But it is also 100 days to the start of the Paralympics in Paris, when elite athletes from across the globe will be going for gold in their chosen field.
O2 removes advert with strobe lighting after people with photosensitive epilepsy raise concerns
The phone network O2 has let us know that they will no longer be screening their most recent advert, ‘Only on priority’, after many people with photosensitive epilepsy raised concerns that the strobe lighting that appears from the beginning could trigger seizures.
“Game-changing” new laser beam therapy will help to reduce seizures in some patients with epilepsy
The NHS will roll out world-leading laser beam therapy to help reduce seizures in a small number of people with drug-resistant epilepsy from next month.
New research finds half of people living with Dravet Syndrome experience feeding problems
A study that was jointly funded by the Epilepsy Society has found that over half (52 per cent) of children and adults with Dravet Syndrome have experienced some form of feeding problem, with some reporting multiple issues.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
We're open:
Monday and Wednesday - 9am to 7.30pm
Tuesday, Thursday, and Friday - 9am to 4pm
Saturday - 9am to 12.30pm
You can also reach us by email
helpline@epilepsysociety.org.uk.